InsiderTrades

Form 4 for SNA Snap-on

Accepted 2025-02-18 00:00:00 ET · period of report 2025-02-13 · accession 0001127602-25-005280 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-02-18 2025-02-13 SNA OZOLINS MARTY V. VP, Ctrl M - OptEx — +22 1,344 +2% —
D 2025-02-18 2025-02-13 SNA OZOLINS MARTY V. VP, Ctrl F - Tax $339.73 -22 1,322 -2% -$7,474
DM 2025-02-18 2025-02-13 SNA OZOLINS MARTY V. VP, Ctrl M - OptEx — -22 0 -100% —
DM 2025-02-18 2025-02-13 SNA OZOLINS MARTY V. VP, Ctrl A - Grant $0.00 +1,862 1,068 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-02-13 M A 22 — 1,343.89 D — — (F1) Based on Company performance during the 2022-2024 period, 107.8% of the performance units vested (as previously disclosed, the reporting person had the opportunity to earn up to 200% of the number originally reported, subject to plan limits). The reporting person elected to defer the receipt of a portion of the underlying shares.
2 Common Common Stock 2025-02-13 F D 22 $339.73 1,321.89 D — —
3 Derivative Deferred Stock Units 2025-02-13 M A 596 — 2,783.41 D — · — to — 596 Common Stock (F1) Based on Company performance during the 2022-2024 period, 107.8% of the performance units vested (as previously disclosed, the reporting person had the opportunity to earn up to 200% of the number originally reported, subject to plan limits). The reporting person elected to defer the receipt of a portion of the underlying shares. (F5) This information is based on a plan statement dated December 31, 2024, as updated by the transaction being reported. (F3) 1 for 1. (F4) Payment will be made in accordance with the reporting person's deferral election, death, disability or termination of employment.
4 Derivative Performance Units 2025-02-13 A A 499 $0.00 499 D — · — to — 499 Common Stock (F3) 1 for 1. (F9) If the Company achieves certain goals over the 2025-2027 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.
5 Derivative Restricted Stock Units 2025-02-13 A A 250 $0.00 250 D — · 2028-02-13 to 2028-02-13 250 Common Stock (F3) 1 for 1. (F8) The restricted stock units vest three years from the grant date on the date listed above, assuming continued employment.
6 Derivative Performance Units 2025-02-13 A A 45 — 618 D — · — to — 45 Common Stock (F1) Based on Company performance during the 2022-2024 period, 107.8% of the performance units vested (as previously disclosed, the reporting person had the opportunity to earn up to 200% of the number originally reported, subject to plan limits). The reporting person elected to defer the receipt of a portion of the underlying shares. (F3) 1 for 1.
7 Derivative Performance Units 2025-02-13 M D 22 — 596 D — · — to — 22 Common Stock (F1) Based on Company performance during the 2022-2024 period, 107.8% of the performance units vested (as previously disclosed, the reporting person had the opportunity to earn up to 200% of the number originally reported, subject to plan limits). The reporting person elected to defer the receipt of a portion of the underlying shares. (F3) 1 for 1.
8 Derivative Performance Units 2025-02-13 M D 596 — 0 D — · — to — 596 Common Stock (F1) Based on Company performance during the 2022-2024 period, 107.8% of the performance units vested (as previously disclosed, the reporting person had the opportunity to earn up to 200% of the number originally reported, subject to plan limits). The reporting person elected to defer the receipt of a portion of the underlying shares. (F3) 1 for 1.
9 Derivative Stock Option (Right to Buy) 2025-02-13 A A 1,068 $0.00 1,068 D $339.73 · 2026-02-13 to 2035-02-13 1,068 Common Stock (F7) This transaction was an option grant. Accordingly, the reporting person did not pay a price to obtain the option. (F6) Original stock option grant vests in three annual installments beginning on the date listed in the "Date Exercisable" column.